Sign in to continue:

Wednesday, July 29th, 2026

Chongqing Yukaifa Announces Adjusted Private Placement Plan: Reduces Fundraising to 81.14 Million Yuan for Real Estate Projects (2026 Board Meeting Resolution)

重庆渝开发股份有限公司董事会决议详细解读

重庆渝开发股份有限公司董事会决议重大调整,定增计划缩减至3,000万股,募资8,114.32万元

一、关键要点

  • 公司向特定对象发行股票方案大幅调整,发行数量从不超过16,500万股缩减至不超过3,000万股,募集资金总额由不超过6.4亿元调整为不超过8,114.32万元。
  • 重庆市城市建设投资(集团)有限公司(重庆城投)作为控股股东,将以现金方式认购不低于本次发行数量的5%且不超过30%,其参与构成关联交易。
  • 募集资金将专用于“格莱美城项目”和“贯金和府一期项目”,两项目均为普通住宅开发且已取得预售许可证并已预售。
  • 此次发行价格不低于定价基准日前20个交易日公司A股均价的80%,且不低于最近一期经审计的每股净资产值,最终价格由董事会和主承销商协商确定。
  • 发行完成后,重庆城投认购股份锁定期为18个月,其他对象为6个月。
  • 本次调整不改变公司实际控制人,仍为重庆市国资委。
  • 相关议案已获独立董事及审计与风险管理委员会通过,部分涉及关联交易的议案董事回避表决。

二、对股东和投资者的重要影响及潜在股价影响因素

  • 定增规模大幅缩减,潜在稀释压力减轻:原计划发行16,500万股,现缩减至3,000万股,极大降低了对现有股东持股比例的稀释压力,有利于维护现有股东利益。
  • 控股股东认购,彰显对公司信心:重庆城投作为控股股东将以现金方式认购5%-30%股份,显示对公司发展的坚定支持,且认购股份锁定期长达18个月,有助于市场稳定。
  • 募集资金专投住宅项目,项目盈利预期明确:募集资金全部投向已取得预售许可证并在售的住宅项目(格莱美城、贯金和府一期),有望加快项目进度,提升公司业绩。
  • 发行价格保护机制,防止低价发行:发行价格设有底线,有效避免低价发行损害公司及股东利益。
  • 本次调整获得监管认可,合规操作降低政策风险:本次调整系根据深圳证券交易所和证监会意见所作,合规性强,减少政策性不确定性。
  • 关联交易严格表决,独立性保障:所有涉及关联交易议案,关联董事均已回避表决,独立董事参与决策,增强决策透明度。

三、详细内容梳理

1. 发行方案主要调整

公司根据监管部门意见,对定增方案进行重大调整。发行数量从16,500万股大幅缩减至3,000万股,募集资金总额由6.4亿元降至8,114.32万元。扣除发行费用后,资金将全部用于格莱美城项目(拟投入1,516.13万元)和贯金和府一期项目(拟投入6,598.19万元),两个项目总投资金额分别为160,060.85万元和104,545.86万元。公司承诺如实际募资低于拟投入金额,将以自有或自筹资金补足,且可先行投入,后续以募集资金置换。

2. 发行对象及定价机制

本次发行对象为不超过35名特定对象,包括控股股东重庆城投(认购5%-30%股份),其余为符合证监会规定的机构投资者或自然人。发行价格不低于定价基准日前20个交易日A股均价80%且不低于最近一期每股净资产,最终价格由竞价确定。若期间有除权除息事项将进行调整。

3. 关联交易及决策流程

重庆城投为控股股东且公司董事长陈业任职其高管,相关议案构成关联交易,董事会表决时陈业回避。所有重要议案均已独立董事会和审计与风险管理委员会会议审议通过。

4. 发行锁定期安排

重庆城投认购股份自发行结束起18个月内不得转让,其他对象为6个月,后续减持须遵守监管规定,因送股、转增等新增股份同样限售。

5. 利润分配及上市安排

发行前的滚存未分配利润由新老股东按持股比例共享。本次发行的股票将在深交所上市,发行决议有效期至2026年7月19日。

6. 相关公告同步披露

上述议案涉及的详细方案、预案、论证分析报告、资金运用可行性分析报告、补充协议及关联交易公告等,均已在《中国证券报》《证券时报》《上海证券报》及巨潮资讯网同步披露,投资者可查阅详细文件。

四、投资者须知及风险提示

  • 本次定增方案大幅缩减,有助于提升每股收益预期,减少稀释效应,或对公司股价形成正面影响。
  • 控股股东大比例认购并锁定18个月,体现对公司前景的信心,有利于稳定股价。
  • 募集资金全部投向已在售项目,项目盈利可期,但最终能否如期达成目标仍受市场及房地产行业波动影响。
  • 后续方案落地仍需获得证监会最终注册同意,存在审批不确定性。

免责声明:本新闻稿内容仅供投资者参考,不构成任何投资建议。投资者应根据自身实际情况和风险承受能力做出独立判断,谨慎投资。公司定增事项尚需履行后续监管审批流程,存有不确定性。
English Version (for reference)
Detailed Analysis of Chongqing Yu Development Co., Ltd. Board Resolutions

Chongqing Yu Development: Major Adjustment to Private Placement Plan, Issuance Reduced to 30 Million Shares, Fundraising Capped at RMB 81.1432 Million

Key Points

  • Company’s private placement plan drastically adjusted: share issue reduced from up to 165 million to 30 million shares; fundraising cap slashed from RMB 640 million to RMB 81.1432 million.
  • Chongqing Urban Construction Investment (Group) Co., Ltd. (“Chongqing Chengtou”), the controlling shareholder, will subscribe for not less than 5% and not more than 30% of the issuance in cash, constituting a related-party transaction.
  • Funds will be dedicated to the “Grand Glamour City Project” (格莱美城) and “Guanjin He Mansion Phase I Project” (贯金和府一期), both regular residential projects with pre-sale permits and already in pre-sale.
  • Issuance price not lower than 80% of the average A-share price over 20 trading days prior to pricing date, and not lower than audited net asset value per share; final price determined via book-building.
  • Lock-up period: Chengtou’s shares for 18 months, other investors for 6 months.
  • After this adjustment, the company’s ultimate controller remains Chongqing SASAC.
  • All related-party proposals approved by independent directors and audit committee; related directors abstained from voting.

Key Impacts for Shareholders & Potential Price Movers

  • Substantial reduction in new shares eases dilution concerns: Drastically lessens dilution risk for existing shareholders—positive for share value.
  • Controlling shareholder subscription shows confidence: Chengtou’s significant cash subscription and long lock-up period should help stabilize the market and boost confidence.
  • Proceeds earmarked for residential projects in pre-sale: Directing all funds to ongoing projects could speed up execution and enhance revenue, supporting future earnings.
  • Pricing floor mechanism protects shareholders from deep discounting.
  • Regulatory compliance and transparent process: Adjustments are regulator-driven, lowering policy risk.
  • Strict related-party transaction governance: All related-party matters were decided with proper abstention and independent director oversight.

Detailed Breakdown

1. Main Plan Adjustments

Based on SZSE and CSRC feedback, the company slashed the share issue and fundraising size. All proceeds after expenses will go to two pre-sale residential projects (Glamour City: RMB 15.16m; Guanjin He Mansion: RMB 65.98m). If actual net proceeds fall short, the company will make up the difference with its own capital and may advance funds ahead of fundraising for replacement later.

2. Issuance Target and Pricing

Up to 35 institutional or qualified investors, including Chengtou (taking 5%-30%). Price not lower than 80% of average price over 20 days and no lower than NAV. Book-building will determine final price.

3. Related-Party Transactions and Governance

Chengtou is both controlling shareholder and director Chen Ye’s employer. Related-party matters were voted on with proper abstention and committee oversight.

4. Share Lock-up

Chengtou’s new shares will be locked for 18 months, others for 6 months, in line with regulatory requirements.

5. Profit Distribution and Listing

Prior undistributed profits will be shared among old and new shareholders pro rata. New shares to list on SZSE. Resolution valid until July 19, 2026.

6. Simultaneous Disclosure

All relevant documents and proposals have been disclosed in major media and at www.cninfo.com.cn for investor reference.

Investor Alert & Risk Disclosure

  • This major adjustment will likely reduce dilution and improve per-share earnings, potentially supporting share price.
  • Chengtou’s strong participation and long lock-up period should reassure the market.
  • Proceeds will be invested in active projects, but returns depend on project execution and the wider property market.
  • Plan still subject to final CSRC registration—some uncertainty remains.

Disclaimer: This news report is for informational purposes only and does not constitute investment advice. Investors should make decisions based on their own circumstances and risk tolerance. The private placement plan is still pending regulatory approval and is subject to change.

View 渝 开 发 Historical chart here



Zhejiang KAN Special Materials Announces 2025 Profit Distribution Plan with Cash Dividend of 0.21 Yuan per 10 Shares

浙江凯恩特种材料股份有限公司发布2025年度利润分配预案,拟大幅提升现金分红 要点速览 2025年度拟每10股派...

湖北亨迪药业2025年年度报告摘要:主营业务、财务数据、产品与研发进展分析

湖北亨迪药业股份有限公司2025年年度报告重点解读 湖北亨迪药业股份有限公司2025年年度报告详细解读 一、报告要点...

上海安硕信息技术股份有限公司2025年度权益分派实施公告及分红方案详解

安硕信息2025年度权益分派实施公告详细解读 安硕信息2025年度权益分派实施公告详细解读 公告概要 2026年5...